Split skin grafts in the treatment of pyoderma gangrenosum. A report of four cases.

BACKGROUND Pyoderma gangrenosum (PG) is an uncommon necrotising, non-infective ulceration of the skin. The management of PG is aimed at limiting tissue destruction, promoting the healing of the wound, and providing an acceptable cosmetic result. However, skin grafting is normally avoided because of the potential risk of pathergy-the localization of skin damaged by trauma. REPORT We describe the use of split skin grafts in the management of ulcerative pyoderma gangrenosum in 4 patients. RESULTS Our cases demonstrate that split skin grafts are a useful treatment modality in patients with ulcerative PG, producing a good cosmetic result. One case illustrates the importance of ensuring the disease is quiescent prior to grafting, to avoid pathergy. The other cases emphasise the need for prolonged immunosuppressive therapy to minimise the chance of reactivation of the disease process. CONCLUSION Our preliminary experience of 4 cases of ulcerative PG indicates that split skin grafts have a role to play in its management. The ultimate cosmetic result is considered to be superior to allowing the wound to heal by secondary intention. To limit the risk of pathergy developing, our experience suggests a role for prolonged courses of immunosuppressive therapy. The most effective dose and duration of immunosuppressive therapy in patients with PG treated with split skin grafts remains to be determined. A controlled study would be of benefit to compare it with other current treatment options.

[1]  S. Burge,et al.  Lesson of the week: Early diagnosis of pyoderma gangrenosum is important to prevent disfigurement , 1998, BMJ.

[2]  W. Su,et al.  Pyoderma gangrenosum: classification and management. , 1996, Journal of the American Academy of Dermatology.

[3]  J. Jessop,et al.  Minimizing the risk of post‐operative pyoderma gangrenosum , 1992, The British journal of dermatology.

[4]  S. Milgraum,et al.  Pyoderma gangrenosum in infancy: the youngest reported patient. , 1991, Journal of the American Academy of Dermatology.

[5]  L. Leape,et al.  Pyoderma gangrenosum occurring at multiple surgical incision sites. , 1987, Gastroenterology.

[6]  D. Jc,et al.  Pyoderma gangrenosum: skin grafting after preparation with hyperbaric oxygen. , 1987 .

[7]  R. Percival,et al.  Pyoderma gangrenosum after cholecystectomy. , 1986, British medical journal.

[8]  C. Vickers,et al.  Pyoderma gangrenosum treated with cyclosporin A , 1985, The British journal of dermatology.

[9]  W. Su,et al.  Pyoderma gangrenosum: a review of 86 patients. , 1985, The Quarterly journal of medicine.

[10]  P. McKeown,et al.  Pyoderma gangrenosum at the parastomal site in patients with Crohn's disease. , 1984, Archives of surgery.

[11]  H. Perry,et al.  Pyoderma gangrenosum in childhood. , 1984, Archives of dermatology.

[12]  S. Schwaitzberg,et al.  Pyoderma gangrenosum. A possible cause of wound necrosis. , 1982, Archives of surgery.

[13]  G. Lazarus,et al.  Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum. , 1982, Archives of dermatology.

[14]  R. Bart,et al.  Postsurgical, chronic, nonprogressive, cutaneous ulcers: a possible variant of pyoderma gangrenosum associated with diabetes mellitus. , 1978, The Journal of dermatologic surgery and oncology.

[15]  D. W. Acker,et al.  Triamcinolone and pyoderma gangrenosum. , 1972, Archives of dermatology.